Furthermore, we report the bottom 10 with least significant interactions (Figure S3A‐C), representing biomarkers that trend the same way in LGL leukemia irrespective of STAT3 mutation status. This evidence concerns the gene STAT3 and T-cell large granular lymphocyte leukemia.